Promacta tended to boost platelet counts in patients with low-risk MDS, and helped those patients be independent of transfusions, too. Promacta (eltrombopag) improved platelet counts in patients with ...
A group of 12 thrombocytopenic patients, ranging in age from two to fourteen years, were studied. The thrombocytopenia was due to diverse conditions (Table 1). The platelet count ranged from 3000 to ...
A new method for treating and chilling blood platelets may prolong their shelf-life by a week or more, helping to ease chronic shortages that endanger patients needing platelet transfusions. A new ...
Platelet transfusions play a major role in the management of thrombocytopenia in hematological and oncologic patients. However, a proportion of these patients become refractory to the transfusion of ...
DURING studies of blood viscosity with a method designed to determine resistance to flow in very small blood vessels, it was unexpectedly found that very high pressures became necessary to force blood ...
People with MDS have fewer red and white blood cells and platelets. Blood transfusions may be needed if you have MDS and experience anemia or thrombocytopenia. Myelodysplastic syndromes (MDS) are a ...
Platelet transfusion thresholds in according bleeding risk and the presence of bleeding. WHO = World Health Organization. “In practice, we see all too often [that] prophylactic transfusion of ...
Turbulence is a critical physical factor that promotes the large-scale production of functional platelets from human induced pluripotent stem cells, researchers reportl. Exposure to turbulent energy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results